Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Revista Ibérica de Sistemas e Tecnologias de Informação ; - (E51):110-126, 2022.
Artículo en Español | ProQuest Central | ID: covidwho-2112117

RESUMEN

Palabras-clave: Puede introducir hasta cinco palabras clave, separadas por punto y coma Please provide : Tackling online education was not easy because one has to be at the forefront with the advancement of information and communication technology (ICT) to obtain quality education. The objective is to analyze and describe the perspectives of the use of ICT to evaluate the activities of university students during online education, the methodology is descriptive-correlational predictive with quantitative approach, with a sample of 1613 surveys, a validated and contextualized measurement instrument is used in Peru, which has questions about the use of ICT for the evaluation of activities, resulting in a valid Cronbachs Alpha (0.969) as also the different statistical tests are optimal for the scientific community. Concluding that there are significantly positive changes in the students who adapt and accept the evaluation system with the use of ICT to improve their learning. Muchos investigadores concluyen que las actividades de tipo colaborativo tienen efectos significativos y positivos para el desarrollo del aprendizaje, sin embargo, el tutor aquí juega un rol muy importante con la educación y aprendizaje combinado pues la comunicación entre estudiante y docente aportó y causó efectos en el rendimiento del estudiante con calificaciones

2.
Rev Esp Geriatr Gerontol ; 56(3): 157-165, 2021.
Artículo en Español | MEDLINE | ID: covidwho-1108647

RESUMEN

Older people living in nursing homes fulfil the criteria to be considered as geriatric patients, but they often do not have met their health care needs. Current deficits appeared as a result of COVID-19 pandemic. The need to improve the coordination between hospitals and nursing homes emerged, and in Madrid it materialized with the implantation of Liaison Geriatrics teams or units at public hospitals. The Sociedad Española de Geriatría y Gerontología has defined the role of the geriatricians in the COVID-19 pandemic and they have given guidelines about prevention, early detection, isolation and sectorization, training, care homes classification, patient referral coordination, and the role of the different care settings, among others. These units and teams also must undertake other care activities that have a shortfall currently, like nursing homes-hospital coordination, geriatricians visits to the homes, telemedicine sessions, geriatric assessment in emergency rooms, and primary care and public health services coordination. This paper describes the concept of Liaison Geriatrics and its implementation at the Autonomous Community of Madrid hospitals as a result of COVID-19 pandemic. Activity data from a unit at a hospital with a huge number of nursing homes in its catchment area are reported. The objective is to understand the need of this activity in order to avoid the current fragmentation of care between hospitals and nursing homes. This activity should be consolidated in the future.


Asunto(s)
COVID-19/epidemiología , Geriatría/organización & administración , Hogares para Ancianos/organización & administración , Casas de Salud/organización & administración , Pandemias , Anciano , Anciano de 80 o más Años , COVID-19/diagnóstico , COVID-19/prevención & control , Servicio de Urgencia en Hospital/legislación & jurisprudencia , Servicio de Urgencia en Hospital/organización & administración , Evaluación Geriátrica , Geriatras/organización & administración , Geriatras/provisión & distribución , Administración de los Servicios de Salud , Hogares para Ancianos/clasificación , Hospitales Públicos/organización & administración , Humanos , Casas de Salud/clasificación , Pandemias/prevención & control , Aislamiento de Pacientes , Atención Primaria de Salud/organización & administración , Administración en Salud Pública , Derivación y Consulta/organización & administración , SARS-CoV-2/inmunología , Estudios Seroepidemiológicos , España/epidemiología , Telemedicina/organización & administración
3.
Mult Scler Relat Disord ; 44: 102306, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: covidwho-616601

RESUMEN

BACKGROUND AND AIM: In December 2019, the first cases of SARS-CoV-2 infection were detected in Wuhan. Within two months, it had begun to spread around the world in what became an unprecedented pandemic. Patients with Multiple Sclerosis (MS) in a state of immunosuppression may be considered at risk for complications in the COVID-19 pandemic, although there is increasing evidence postulating a possible protective role of selective immunosuppression. One group of such immunosuppressants used in MS comprises the anti-CD20 monoclonal antibodies (mAbs) ocrelizumab and rituximab. Anti-CD20 mAbs bind to the surface of B cells, causing their depletion. We describe our experience in seven cases of patients with multiple sclerosis who have been affected by SARS-COV-2 (with a clinical/serological diagnosis or PCR diagnosis) and who were being treated with anti-CD20+ monoclonal antibodies. MATERIAL AND METHODS: We review the development of patients during infection as well as the resolution of their clinical picture. We also analyze the serology status against SARS-CoV-2 after resolution of the infection. RESULTS: Although the severity of the clinical pictures was variable, patients' development was good. Not all patients, however, developed antibodies against SARS-CoV-2. CONCLUSIONS: Patients treated with anti-CD20+ have adequate resolution of COVID-19 despite the fact that the presence of antibodies against SARS-CoV-2 was not detected in all cases. It is possible that the presence of humoral immunity is not always necessary fora good clinical course of SARS-CoV-2 infection.


Asunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Antígenos CD20/inmunología , COVID-19/inmunología , Factores Inmunológicos/uso terapéutico , Esclerosis Múltiple/tratamiento farmacológico , Esclerosis Múltiple/inmunología , Rituximab/uso terapéutico , Adulto , COVID-19/complicaciones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/complicaciones , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA